ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

Phase 2

Completed

Conditions: Stable Angina

Interventions: Drug: Intravenous Glycoprotein inhibitor + ASA, Clopidogrel
Drug: Antiplatelet Therapy (ASA, Clopidogrel)

First Posted Date: 2010-04-14

Last Posted Date: 2018-02-14

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 36

Registration Number: NCT01103440

Locations: 🇺🇸
Mount Sinai Medical Center, New York, New York, United States

Management Practices and the Risk of Infection Following Cardiac Surgery

Completed

Conditions: Postoperative Wound Infection
Cardiac Surgery
Infection, Postoperative Wound
Infections, Nosocomial
Management Practices

First Posted Date: 2010-03-18

Last Posted Date: 2014-04-08

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 5158

Registration Number: NCT01089712

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇨🇦
Montreal Heart Institute, Montreal, Quebec, Canada
🇺🇸
Montefiore Einstein Heart Center, Bronx, New York, United States

and more 7 locations

Prolonging Remission in Depressed Elderly (PRIDE)

Phase 4

Completed

Conditions: Depression

Interventions: Drug: lithium and Venlafaxine
Procedure: ECT

First Posted Date: 2009-12-09

Last Posted Date: 2017-04-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 247

Registration Number: NCT01028508

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
Wake Forest University Medical Center, Winston-Salem, North Carolina, United States
🇺🇸
Hoboken University Medical Center (MSSM satellite site), Hoboken, New Jersey, United States

and more 7 locations

Prevent Return of Stroke Study

Not Applicable

Completed

Conditions: Transient Ischemic Attack
Stroke Recurrence

Interventions: Behavioral: Prevent Return of Stroke

First Posted Date: 2009-12-07

Last Posted Date: 2014-07-31

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 600

Registration Number: NCT01027273

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes

Not Applicable

Completed

Conditions: Pre-diabetes

Interventions: Behavioral: Peer-Led Lifestyle Education on Weight Loss

First Posted Date: 2009-10-30

Last Posted Date: 2014-10-23

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 402

Registration Number: NCT01004848

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients

Completed

Conditions: Stent Thrombosis
Medication Non-adherence

First Posted Date: 2009-10-20

Last Posted Date: 2016-02-11

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 5031

Registration Number: NCT00998127

Locations: 🇺🇸
Heart Center of Indiana, Indianapolis, Indiana, United States
🇺🇸
Washington Adventist Hospital, Takoma Park, Maryland, United States
🇺🇸
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States

and more 12 locations

Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery

Phase 3

Terminated

Conditions: Post-Operative Delirium
Postoperative Cognitive Dysfunction

Interventions: Procedure: SctO2 < 60 %.

First Posted Date: 2009-10-08

Last Posted Date: 2016-09-16

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 15

Registration Number: NCT00991328

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy

Phase 1

Completed

Conditions: Diabetic Nephropathy

Interventions: Drug: Sevelamer Carbonate
Drug: Calcium Carbonate

First Posted Date: 2009-08-28

Last Posted Date: 2011-11-18

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 20

Registration Number: NCT00967629

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

The Role Of Omega-3 Fatty Acids In Adolescent Depression

Phase 2

Completed

Conditions: Depressive Disorder, Major

Interventions: Dietary Supplement: Corn oil
Drug: Omega 3 Fatty Acids

First Posted Date: 2009-08-20

Last Posted Date: 2018-04-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 16

Registration Number: NCT00962598

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema

Phase 1

Conditions: Diabetic Macular Edema

Interventions: Drug: Infliximab (intravitreal, 2.0mg/0.05ml)

First Posted Date: 2009-08-17

Last Posted Date: 2009-08-17

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 10

Registration Number: NCT00959725

Locations: 🇺🇸
Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy